Dr. Jean, Dr. Blaise and Dr. Wasserfallen talk about European team perspective on guidelines 

Dr. Wexner and Dr. Groah give his lecture about what drove the CMS ACS AORN AHA Am Society of Anesthesiologists Guidelines. 

​Robots for all aspects of infectious diseases, from health care to how individuals cope! 




In 2015 during the west Africa Ebola outbreak, the White House OSTP with multiple universities and agencies, the National Science Foundation, and the Texas A&M Engineering Extension Service sponsored workshops on robotics (ground, aerial, marine).  Since Ebola didn’t turn into a global threat, at the time things didn’t progress much farther than those workshops, but there’s now a ...

Spot is a robot with dog appearance designed by Boston Dynamics. It has been used during two weeks in a hospital in Boston – Brigham and Women’s Hospital – to help minimize the staff exposure to the Covid-19. The medical team is using the robot as a telemedicine platform, allowing healthcare providers to remotely triage patients. 




Click here for reference

Wireless sensor gently sits on throat to monitor coughs, fever and respiratory activity.


The more we learn about the novel coronavirus (COVID-19), the more unknowns seem to arise. These ever-emerging mysteries highlight the desperate need for more data to help researchers and physicians better understand — and treat — the extremely contagious and deadly disease.

Researchers at Northwestern University and Shirley Ryan AbilityLab in Chicago have developed a nov...

Developed in just six weeks, the rapid test can detect a SARS-CoV-2 coronavirus infection in patients in under two and a half hours. The test for COVID-19 can help medical facilities make fast diagnoses and play a part in containing the coronavirus pandemic.



Click here for reference

The US drug regulator has granted its first emergency-use approval for a new coronavirus test that takes advantage of the gene-editing technology CRISPR on 6 May.

The US Food and Drug Administration’s (FDA) emergency-use authority allows it to make tests and drugs available faster than usual in a public-health emergency. The new diagnostic kit is based on an approach co-developed by CRISPR pioneer Feng Zhang at the Broad Institute of MIT and Harvard in Cambridge, Massachusetts. It ...

A group of researchers, including some at IMIM, design a new support tool for the diagnosis of COVID-19 which uses Artificial Intelligence. It has been trained with more than 6,000 chest X-rays of patients from the Hospital del Mar.




The researcher at the Hospital del Mar Medical Research Institute (IMIM) and physician at the Hospital del Mar Emergency Service, Max Hardy-Werbin, as well as the bioinformatician at the Pathological Anatomy Service of the same hospital, Joan Gi...

Liming Bio has launched The StrongStep® COVID-19 IgG/IgM Combo Test. It is a rapid immunochromatographic assay for the simultaneous detection of IgG and IgM antibodies to SARS-CoV-2 virus in human whole blood, serum or plasma. The assay is used as an aid in the diagnosis of COVID-19.

Click here for reference

A combination of three antiviral drugs plus an immune system booster seemed to help patients recover more quickly from coronavirus infections, doctors in Hong Kong reported Friday.



They said the approach needs more testing but it could offer another treatment possibility for Covid-19 patients. Currently the only authorized treatment is the experimental antiviral drug remdesivir, which also shortens the duration of illness but is limited in supply.
Dr. Kwok-Yung Yuen at H...

HP is providing several free-access 3D printing designs for essential materials in the Covid-19 fight, and other additional resources. These materials include face shields, masks, CPAP components, personal accessories, and ventilator components. The webpage is updated regularly. 

Click here to access website

Effective antiviral therapy is important for tackling the coronavirus disease 2019 (COVID-19) pandemic. We assessed the efficacy and safety of combined interferon beta-1b, lopinavir–ritonavir, and ribavirin for treating patients with COVID-19. This was a multicentre, prospective, open-label, randomised, phase 2 trial in adults with COVID-19 who were admitted to six hospitals in Hong Kong. Patients were randomly assigned (2:1) to a 14-day combination of lopinavir 400 mg and ritonavir 100 m...